Myelin basic protein antagonizes the SARS-CoV-2 protein ORF3a-induced autophagy inhibition

George A Saratov1, Alexey A Belogurov2, Anna A Kudriaeva3

  • 1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia; Moscow Institute of Physics and Technology (national Research University), Phystech School of Biological and Medical Physics, 141701, Dolgoprudny, Moscow Region, Russia.

Biochimie
|May 4, 2024
PubMed

Insights

Myelin basic protein (MBP) binds SARS-CoV-2 protein ORF3a, restoring inhibited autophagy. MBP

Area of Science:

  • Virology
  • Cell Biology
  • Neuroscience

Background:

  • SARS-CoV-2 infection inhibits autophagy, a crucial cellular process.
  • The viral protein ORF3a disrupts autophagosome-lysosome fusion by interacting with VPS39 and the HOPS complex.
  • Autophagy impairment is a key feature of SARS-CoV-2 pathogenesis.

Purpose of the Study:

  • To investigate the interaction between myelin basic protein (MBP) and SARS-CoV-2 ORF3a.
  • To determine if MBP can counteract ORF3a-mediated autophagy inhibition.
  • To explore the potential protective role of MBP in oligodendrocytes during SARS-CoV-2 infection.

Main Methods:

  • Co-expression of MBP and ORF3a in mammalian cells.
  • Assessment of autophagy flux and colocalization studies.
  • Analysis of MBP variants with altered charge (deaminated MBP).

Main Results:

  • MBP binds to SARS-CoV-2 ORF3a and colocalizes with it in cells.
  • Co-expression of MBP restores autophagy inhibited by ORF3a.
  • The basic charge of MBP is critical for its interaction with ORF3a and restoration of autophagy.

Conclusions:

  • MBP can counteract SARS-CoV-2 ORF3a-induced autophagy inhibition.
  • MBP's interaction with ORF3a and its protective role in autophagy may be significant for oligodendrocytes.
  • Deimination of MBP, observed in multiple sclerosis patients, might worsen COVID-19 outcomes and neurological symptoms.